Survival analysis and factors influencing survival time of adult HIV/AIDS patients receiving antiretroviral therapy from 2012 to 2022 in Chongqing, China: a retrospective cohort study.

ABSTRACT:

Background

Despite expanded antiretroviral therapy (ART) coverage in China, AIDS remains a major public health challenge. This study aimed to assess survival outcomes and identify factors influencing survival time among HIV/AIDS patients receiving ART.

Methods

This study was a retrospective cohort study utilizing data on HIV patients receiving antiretroviral therapy in Jiulongpo District, Chongqing, from 2012 to 2022. Life tables estimated cumulative survival, Kaplan-Meyer compared survival between groups, and accelerated time to failure (AFT) modeling was used for analysis of factors influencing survival time.

Results

The 1-, 3-, 5-, and 10-year cumulative survival rates were 94% (95% CI: 0.93 to 0.95), 90% (95% CI: 0.89 to 0.91), 86% (95% CI: 0.85 to 0.87), and 79%

SUBMITTER: Huang Y 

PROVIDER: S-EPMC12491286 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature